WMIC Poster Presentation

World Molecular Imaging Congress 2022

Download our WMIC 2022 Poster

To request a copy of our poster, please complete the form and you will gain access to download.

wmis-banner-wmic-abstracts-R04-1024x299 (1) - Edited

Imagion Biosystems presented our most recent data related to our prostate cancer imaging agent at the 2022 World Molecular Imaging Congress held in Miami, FL Sep 28 – Oct 1.

The work was presented by Dr. Marie Zhang, VP of Research and Pre-Clinical Development at Imagion Biosystems:

Targeted detection/imaging of prostate cancer by SPMR and MRI using anti-PSMA peptide functionalized iron oxide nanoparticles
Thursday, Sept 29th from 1-2 pm EST in Exhibit Halls B & C

The preclinical results presented provide strong evidence that our magnetic nanoparticle technology can be used to target prostate cancer tumors expressing the Prostate Specific Membrane Antigen (PSMA) with high specificity.

A molecular imaging agent based on magnetic imaging rather than the use of radioactivity will address the large unmet need of making non-invasive detection of prostate cancer more accessible and affordable and could reduce the need for prostate biopsies for many men, saving costs and improving patient care.

A copy of the poster is now made available. You can request a copy here.

Questions about our poster presentation or our technology? Connect with one of our team members: